| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +16.4K | 1.1% | $0.59 | +$9.64K |
| Sells | 2 | -1.5M | 98.9% | $0.58 | -$877K |
| Net | -1 | -1.48M | -97.8% | -$868K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Nasrat A. Hakim | CEO, President, Director, 10%+ Owner | $8.09M | 29 Mar 2024 | ||
| Douglas Plassche | EVP Operations | $3.52M | -$615K | -14.9% | 02 Oct 2025 |
| ELITE PHARMACEUTICALS INC /NV/ | EVP Operations | $129K | -$262K | -67% | 22 Aug 2025 |
| Barry Dash | Director | $118K | 22 Nov 2023 | ||
| JEFFREY WHITNELL | Director | $116K | 22 Nov 2023 | ||
| S. Caskey | Director | $74.8K | 22 Nov 2023 | ||
| Robert Chen | CFO, Secretary, Treasurer | $27K | 16 May 2022 | ||
| Kirko Kirkov | Chief Commercial Officer | $9.64K | +$9.64K | 10 Jul 2025 | |
| Marc Bregman | CFO, Secretary, Treasurer | $9K | 17 May 2021 | ||
| Mark N. Pellegrino | CFO, Secretary, Treasurer | 01 May 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|